Why the study?
The study evaluated the feasibility of a non-invasive biosensor system using single-lead ECG to estimate continuous blood pressure over 24 hours.
Does an AI-based system using single-lead ECG accurately estimate continuous 24-hour blood pressure compared to cuff-based readings?
Does an AI-based system using single-lead ECG accurately estimate continuous 24-hour blood pressure compared to cuff-based readings?
A novel AI-based system integrating consumer wearables and a digital stethoscope shows proof-of-concept feasibility for continuous, cuffless blood pressure monitoring.
Should not yet replace cuff-based BP monitoring; leaves open accuracy of AI single-lead ECG for continuous estimation.[[1]](https://advanced.onlinelibrary.wiley.com/doi/abs/10.1002/adsr.202500134)[[1]](https://advanced.onlinelibrary.wiley.com/doi/abs/10.1002/adsr.
This project explores the development and feasibility of a non‐invasive biosensor system designed to capture cardiac signals and evaluate the validity of estimating blood pressure over a 24‐hour period using a single‐lead electrocardiogram (ECG). The system integrates an Apple Watch, a laboratory‐built digital stethoscope, and a consumer‐grade blood pressure cuff to collect cardiac signals that are processed through a cloud‐based pipeline. An artificial intelligence (AI) model was trained on the publicly available Multiparameter Intelligent Monitoring in Intensive Care II (MIMIC‐II) clinical dataset, which generates a 24‐hour continuous blood pressure prediction waveform from the ECG data, and Autonomic Aging ambulatory dataset. This predicted waveform is averaged and compared with the cuff‐based blood pressure readings to assess accuracy and signal reliability. To further validate the system, cross‐device agreement in beats per minute (BPM) is used to demonstrate the plausibility of cuffless blood pressure tracking. Overall, this study presents a proof‐of‐concept framework for continuous, cuffless blood‐pressure estimation using ECG alone. By combining mechanical heartbeat verification with cloud‐based AI processing, the system demonstrates technical feasibility and provides a foundation for non‐invasive, long‐term monitoring and future clinical validation.
No takes yet. Share an insight, caveat, or question.
Burgess et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: